Cyclacel Pharmaceuticals, Inc. Annual Depreciation in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2013 to 2023.
  • Cyclacel Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $2K, a 75% decline year-over-year.
  • Cyclacel Pharmaceuticals, Inc. annual Depreciation for 2023 was $31K, a 3.13% decline from 2022.
  • Cyclacel Pharmaceuticals, Inc. annual Depreciation for 2022 was $32K, a 25.6% decline from 2021.
  • Cyclacel Pharmaceuticals, Inc. annual Depreciation for 2021 was $43K, a 115% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $31K -$1K -3.13% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $32K -$11K -25.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $43K +$23K +115% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-11-29
2020 $20K $0 0% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $20K -$9K -31% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $29K -$3K -9.38% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 $32K -$101K -75.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
2016 $133K -$77K -36.7% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-30
2015 $210K +$36K +20.7% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 $174K +$104K +149% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-29
2013 $70K Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.